Komori
Medipal Holdings (7459) · RiskRestated

Risk of alliances and other arrangements not proceeding as planned

First written in FY2016. 13 of 15 entries say "Restated". Latest entry: FY2022.

15entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2020-Q3RestatedFY2021-Q2 – FY20222016: 320162017: 220172018: 420182019: 220192020: 320202021: 020212022: 12022
Same theme, other companies
Risks of Unmet Acquisition, Partnership and New Business Investment Plans and Investment LossesA theme 211 companies write about · 213 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2018: 13 of 78 companies on the "Worse" side.

99 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 198 companies compared. The sentences above are computed from all 198.Comparing 200 of the theme's 213 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2022RestatedAnnual report

    「Before entering into such capital and business alliances, we examine profitability and the potential for recovering our investments from various perspectives. However, if unexpected changes in the operating environment or a significant deviation from the assumed business plan occurs, impairment losses or other expenses may arise, potentially affecting the Group's operating performance and financial position.」

    Regarding capital and business alliances, the company continues to disclose the risk that deviations from plans and impairment losses may affect operating performance, while examining profitability and the potential for recovering investments.
  2. FY2021-Q2RestatedAnnual report

    「During the first six months of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the risk that partnerships and other initiatives will not proceed as planned.
  3. FY2020WorsenedAnnual report

    「In line with the basic policy of its medium-term vision, "Building a new framework that contributes to society and customers and achieving expansion of the earnings base and sustainable growth," the Group is actively pursuing investments in startup companies, including venture companies in the life sciences field, as well as partnerships across industry boundaries in fields such as digital services and logistics. Before entering into such capital and business alliances, the Group examines profitability and the potential for recovering its investments from various perspectives. However, if unexpected changes in the operating environment or a significant deviation from the assumed business plan occurs, impairment losses or other expenses may arise, potentially affecting the Group's operating performance and financial position.」

    Regarding the risk of partnerships falling short of plan, the company specified that the scope includes investments in life sciences startups and partnerships in the digital and logistics fields, and disclosed the risk of impairment losses if plans deviate materially.
  4. FY2020-Q3RestatedAnnual report

    「No new business or other risks arose during the cumulative third quarter under review. In addition, there have been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the risk that partnerships and other initiatives will not proceed as planned.
  5. FY2020-Q2RestatedAnnual report

    「During the first six months of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the risk that partnerships and other initiatives will not proceed as planned.
  6. FY2019-Q3RestatedAnnual report

    「No new business or other risks arose during the cumulative third quarter under review. In addition, there have been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the risk that partnerships and other initiatives will not proceed as planned.
  7. FY2019-Q2RestatedAnnual report

    「During the first six months of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the risk that partnerships and other initiatives will not proceed as planned.
  8. FY2019-Q1RestatedAnnual report

    「No new business or other risks arose during the first quarter of the current consolidated cumulative period. There were also no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the risk that partnerships and other initiatives will not proceed as planned.
  9. FY2018RestatedAnnual report

    「If, as a result of these initiatives, partnerships and other arrangements do not proceed as originally planned, this may affect the Group's financial position and operating results.」

    The company continues to identify the risk that partnerships and the use of external resources will not proceed as planned.
  10. FY2018-Q3RestatedAnnual report

    「No new business or other risks arose during the cumulative third quarter under review. In addition, there have been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the risk that partnerships and other initiatives will not proceed as planned.
  11. FY2018-Q2RestatedAnnual report

    「During the first six months of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the risk that partnerships and other initiatives will not proceed as planned.
  12. FY2017-Q3RestatedAnnual report

    「No new business or other risks arose during the cumulative third quarter under review. In addition, there have been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the risk that partnerships and other initiatives will not proceed as planned.
  13. FY2017-Q2RestatedAnnual report

    「During the first six months of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the risk that partnerships and other initiatives will not proceed as planned.
  14. FY2017-Q1RestatedAnnual report

    「No new business or other risks arose during the first quarter of the current consolidated cumulative period. There were also no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the risk that partnerships and other initiatives will not proceed as planned.
  15. FY2016First statedAnnual report

    「Although the Group conducts sufficient and careful reviews when entering into partnerships and similar arrangements, if these initiatives do not proceed as originally planned, this may affect its financial position and operating results.」

    The company identifies the risk of falling short of plan targets while pursuing partnerships and the use of external resources as means of growth.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Medipal Holdings's next results are scheduled for 2026-11-05. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.